Ideaya Biosciences Inc. logo

Ideaya Biosciences Inc. (IDYA)

Market Closed
27 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
36. 77
+1.37
+3.8701%
$
3.37B Market Cap
- P/E Ratio
- Div Yield
1.06M Volume
-1.91 Eps
$ 35.4
Previous Close
Add Transaction
Day Range
35.17 37.06
Year Range
22.09 40.58
Want to track IDYA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ideaya Biosciences Inc. (IDYA) Statistics

Valuation metrics

Market Cap 3.37B
Enterprise value 3.24B
Trailing P/E (ttm) -22.41
Forward P/E -7.6
PEG ratio -0.51
Price/Sales (ttm) 14.94
Price/Book (mrq) 3.35
Enterprise Value/Revenue 14.37
Enterprise Value/EBITDA -23.9

Overview

Shares outstanding 87.86M
Float 87.01M
Shares short 11.71M
% Held by insiders 0.02%
% Held by institutions 1.11%
Average volume (10 days) 790.8K
Average volume (90 days) 851.37K

Price summary

52-Week low 22.09
52-Week high 40.58
Beta -0.04
50-Day moving average 31.16
200-Day moving average 32.09

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.62%
Operating margin -0.81%

Operational effectiveness

Return on assets -0.14%
Return on equity -0.14%

Income Statement

Revenue (ttm) 225.27M
Revenue per share (ttm) 2.54
Quarterly revenue growth (yoy) 0.55%
Gross profit (ttm) -114.27M
EBITDA -180.68M
Net income to common (ttm) -140.06M
Diluted EPS (ttm) -1.58
Quarterly earnings growth (yoy) 0.55%

Balance Sheet

Total cash (mrq) 671.2M
Total cash per share (mrq) 7.57
Total debt (mrq) 28.6M
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 10.74%
Book value per share (mrq) 10.57

Cash Flow

Cash flow statement -85.93M
Levered free cash flow (LFCF) -57.25M